0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Porcine Vaccine Market Outlook 2021
Published Date: December 2020
|
Report Code: QYRE-Auto-31B3727
Home | Market Reports | Health | Health Conditions | Infectious Diseases
Global Porcine Vaccine Market Outlook 2021

Global Porcine Vaccine Market Outlook 2021

Code: QYRE-Auto-31B3727
Report
December 2020
Pages:92
QYResearch
Description
Table of Content
Tables & Figures
The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2015 to 2026. Understanding the segments helps in identifying the importance of different factors that aid the market growth.
Segment by Type, the Porcine Vaccine market is segmented into
    Inactivated Vaccines
    Live Attenuated Vaccines
    Toxoid Vaccines
    Recombinant Vaccines
    Conjugate Vaccines
    DNA Vaccines
Segment by Application
    Veterinary Hospitals
    Hog/Pig Production Farm
Global Porcine Vaccine Market: Regional Analysis
The Porcine Vaccine market is analysed and market size information is provided by regions (countries). The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type and by Application segment in terms of sales and revenue for the period 2015-2026.
The key regions covered in the Porcine Vaccine market report are:
    North America
        U.S.
        Canada
    Europe
        Germany
        France
        U.K.
        Italy
        Russia
    Asia-Pacific
        China
        Japan
        South Korea
        India
        Australia
        Taiwan
        Indonesia
        Thailand
        Malaysia
        Philippines
        Vietnam
    Latin America
        Mexico
        Brazil
        Argentina
    Middle East & Africa
        Turkey
        Saudi Arabia
        U.A.E
Global Porcine Vaccine Market: Competitive Analysis
This section of the report identifies various key manufacturers of the market. It helps the reader understand the strategies and collaborations that players are focusing on combat competition in the market. The comprehensive report provides a significant microscopic look at the market. The reader can identify the footprints of the manufacturers by knowing about the global revenue of manufacturers, the global price of manufacturers, and sales by manufacturers during the forecast period of 2015 to 2019.
The major players in global Porcine Vaccine market include:
    Bayer AG.
    Bimeda Animal Health
    Boehringer Ingelheim GmbH
    Ceva Sante Animale
    Eli Lilly
    Merck & Co., Inc.
    Merial (Sanofi)
    Vetoquinol
    Zoetis, Inc.
1 Porcine Vaccine Market Overview
1.1 Product Overview and Scope of Porcine Vaccine
1.2 Porcine Vaccine Segment by Type
1.2.1 Global Porcine Vaccine Sales Growth Rate Comparison by Type (2020-2026)
1.2.2 Inactivated Vaccines
1.2.3 Live Attenuated Vaccines
1.2.4 Toxoid Vaccines
1.2.5 Recombinant Vaccines
1.2.6 Conjugate Vaccines
1.2.7 DNA Vaccines
1.3 Porcine Vaccine Segment by Application
1.3.1 Porcine Vaccine Sales Comparison by Application: (2020-2026)
1.3.2 Veterinary Hospitals
1.3.3 Hog/Pig Production Farm
1.4 Global Porcine Vaccine Market Size Estimates and Forecasts
1.4.1 Global Porcine Vaccine Revenue 2015-2026
1.4.2 Global Porcine Vaccine Sales 2015-2026
1.4.3 Porcine Vaccine Market Size by Region: 2020 Versus 2026
2 Global Porcine Vaccine Market Competition by Manufacturers
2.1 Global Porcine Vaccine Sales Market Share by Manufacturers (2015-2020)
2.2 Global Porcine Vaccine Revenue Share by Manufacturers (2015-2020)
2.3 Global Porcine Vaccine Average Price by Manufacturers (2015-2020)
2.4 Manufacturers Porcine Vaccine Manufacturing Sites, Area Served, Product Type
2.5 Porcine Vaccine Market Competitive Situation and Trends
2.5.1 Porcine Vaccine Market Concentration Rate
2.5.2 Global Top 5 and Top 10 Players Market Share by Revenue
2.5.3 Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
2.7 Primary Interviews with Key Porcine Vaccine Players (Opinion Leaders)
3 Porcine Vaccine Retrospective Market Scenario by Region
3.1 Global Porcine Vaccine Retrospective Market Scenario in Sales by Region: 2015-2020
3.2 Global Porcine Vaccine Retrospective Market Scenario in Revenue by Region: 2015-2020
3.3 North America Porcine Vaccine Market Facts & Figures by Country
3.3.1 North America Porcine Vaccine Sales by Country
3.3.2 North America Porcine Vaccine Sales by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Porcine Vaccine Market Facts & Figures by Country
3.4.1 Europe Porcine Vaccine Sales by Country
3.4.2 Europe Porcine Vaccine Sales by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Porcine Vaccine Market Facts & Figures by Region
3.5.1 Asia Pacific Porcine Vaccine Sales by Region
3.5.2 Asia Pacific Porcine Vaccine Sales by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America Porcine Vaccine Market Facts & Figures by Country
3.6.1 Latin America Porcine Vaccine Sales by Country
3.6.2 Latin America Porcine Vaccine Sales by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa Porcine Vaccine Market Facts & Figures by Country
3.7.1 Middle East and Africa Porcine Vaccine Sales by Country
3.7.2 Middle East and Africa Porcine Vaccine Sales by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 U.A.E
4 Global Porcine Vaccine Historic Market Analysis by Type
4.1 Global Porcine Vaccine Sales Market Share by Type (2015-2020)
4.2 Global Porcine Vaccine Revenue Market Share by Type (2015-2020)
4.3 Global Porcine Vaccine Price Market Share by Type (2015-2020)
4.4 Global Porcine Vaccine Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Global Porcine Vaccine Historic Market Analysis by Application
5.1 Global Porcine Vaccine Sales Market Share by Application (2015-2020)
5.2 Global Porcine Vaccine Revenue Market Share by Application (2015-2020)
5.3 Global Porcine Vaccine Price by Application (2015-2020)
6 Company Profiles and Key Figures in Porcine Vaccine Business
6.1 Bayer AG.
6.1.1 Corporation Information
6.1.2 Bayer AG. Description, Business Overview
6.1.3 Bayer AG. Porcine Vaccine Sales, Revenue and Gross Margin (2015-2020)
6.1.4 Bayer AG. Products Offered
6.1.5 Bayer AG. Recent Development
6.2 Bimeda Animal Health
6.2.1 Bimeda Animal Health Corporation Information
6.2.2 Bimeda Animal Health Description, Business Overview
6.2.3 Bimeda Animal Health Porcine Vaccine Sales, Revenue and Gross Margin (2015-2020)
6.2.4 Bimeda Animal Health Products Offered
6.2.5 Bimeda Animal Health Recent Development
6.3 Boehringer Ingelheim GmbH
6.3.1 Boehringer Ingelheim GmbH Corporation Information
6.3.2 Boehringer Ingelheim GmbH Description, Business Overview
6.3.3 Boehringer Ingelheim GmbH Porcine Vaccine Sales, Revenue and Gross Margin (2015-2020)
6.3.4 Boehringer Ingelheim GmbH Products Offered
6.3.5 Boehringer Ingelheim GmbH Recent Development
6.4 Ceva Sante Animale
6.4.1 Ceva Sante Animale Corporation Information
6.4.2 Ceva Sante Animale Description, Business Overview
6.4.3 Ceva Sante Animale Porcine Vaccine Sales, Revenue and Gross Margin (2015-2020)
6.4.4 Ceva Sante Animale Products Offered
6.4.5 Ceva Sante Animale Recent Development
6.5 Eli Lilly
6.5.1 Eli Lilly Corporation Information
6.5.2 Eli Lilly Description, Business Overview
6.5.3 Eli Lilly Porcine Vaccine Sales, Revenue and Gross Margin (2015-2020)
6.5.4 Eli Lilly Products Offered
6.5.5 Eli Lilly Recent Development
6.6 Merck & Co., Inc.
6.6.1 Merck & Co., Inc. Corporation Information
6.6.2 Merck & Co., Inc. Description, Business Overview
6.6.3 Merck & Co., Inc. Porcine Vaccine Sales, Revenue and Gross Margin (2015-2020)
6.6.4 Merck & Co., Inc. Products Offered
6.6.5 Merck & Co., Inc. Recent Development
6.7 Merial (Sanofi)
6.6.1 Merial (Sanofi) Corporation Information
6.6.2 Merial (Sanofi) Description, Business Overview
6.6.3 Merial (Sanofi) Porcine Vaccine Sales, Revenue and Gross Margin (2015-2020)
6.4.4 Merial (Sanofi) Products Offered
6.7.5 Merial (Sanofi) Recent Development
6.8 Vetoquinol
6.8.1 Vetoquinol Corporation Information
6.8.2 Vetoquinol Description, Business Overview
6.8.3 Vetoquinol Porcine Vaccine Sales, Revenue and Gross Margin (2015-2020)
6.8.4 Vetoquinol Products Offered
6.8.5 Vetoquinol Recent Development
6.9 Zoetis, Inc.
6.9.1 Zoetis, Inc. Corporation Information
6.9.2 Zoetis, Inc. Description, Business Overview
6.9.3 Zoetis, Inc. Porcine Vaccine Sales, Revenue and Gross Margin (2015-2020)
6.9.4 Zoetis, Inc. Products Offered
6.9.5 Zoetis, Inc. Recent Development
7 Porcine Vaccine Manufacturing Cost Analysis
7.1 Porcine Vaccine Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Raw Materials Price Trend
7.1.3 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Porcine Vaccine
7.4 Porcine Vaccine Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Porcine Vaccine Distributors List
8.3 Porcine Vaccine Customers
9 Market Dynamics
9.1 Market Trends
9.2 Opportunities and Drivers
9.3 Challenges
9.4 Porter's Five Forces Analysis
10 Global Market Forecast
10.1 Global Porcine Vaccine Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Porcine Vaccine by Type (2021-2026)
10.1.2 Global Forecasted Revenue of Porcine Vaccine by Type (2021-2026)
10.2 Porcine Vaccine Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Porcine Vaccine by Application (2021-2026)
10.2.2 Global Forecasted Revenue of Porcine Vaccine by Application (2021-2026)
10.3 Porcine Vaccine Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Porcine Vaccine by Region (2021-2026)
10.3.2 Global Forecasted Revenue of Porcine Vaccine by Region (2021-2026)
11 Research Finding and Conclusion
12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer
List of Tables
    Table 1. Global Porcine Vaccine Sales (K Doses) Growth Rate Comparison by Type (2015-2026)
    Table 2. Global Porcine Vaccine Sales (K Doses) Comparison by Application: 2020 VS 2026
    Table 3. Global Porcine Vaccine Market Size by Type (K Doses) (US$ Million) (2020 VS 2026)
    Table 4. Global Key Porcine Vaccine Manufacturers Covered in This Study
    Table 5. Global Porcine Vaccine Sales (K Doses) by Manufacturers (2015-2020)
    Table 6. Global Porcine Vaccine Sales Share by Manufacturers (2015-2020)
    Table 7. Global Porcine Vaccine Revenue (Million USD) by Manufacturers (2015-2020)
    Table 8. Global Porcine Vaccine Revenue Share by Manufacturers (2015-2020)
    Table 9. Global Market Porcine Vaccine Average Price (USD/Dose) of Key Manufacturers (2015-2020)
    Table 10. Manufacturers Porcine Vaccine Sales Sites and Area Served
    Table 11. Manufacturers Porcine Vaccine Product Types
    Table 12. Global Porcine Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 13. Global Porcine Vaccine by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Porcine Vaccine as of 2019)
    Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
    Table 15. Main Points Interviewed from Key Porcine Vaccine Players
    Table 16. Global Porcine Vaccine Sales (K Doses) by Region (2015-2020)
    Table 17. Global Porcine Vaccine Sales Market Share by Region (2015-2020)
    Table 18. Global Porcine Vaccine Revenue (Million US$) by Region (2015-2020)
    Table 19. Global Porcine Vaccine Revenue Market Share by Region (2015-2020)
    Table 20. North America Porcine Vaccine Sales by Country (2015-2020) (K Doses)
    Table 21. North America Porcine Vaccine Sales Market Share by Country (2015-2020)
    Table 22. North America Porcine Vaccine Revenue by Country (2015-2020) (US$ Million)
    Table 23. North America Porcine Vaccine Revenue Market Share by Country (2015-2020)
    Table 24. Europe Porcine Vaccine Sales by Country (2015-2020) (K Doses)
    Table 25. Europe Porcine Vaccine Sales Market Share by Country (2015-2020)
    Table 26. Europe Porcine Vaccine Revenue by Country (2015-2020) (US$ Million)
    Table 27. Europe Porcine Vaccine Revenue Market Share by Country (2015-2020)
    Table 28. Asia Pacific Porcine Vaccine Sales by Region (2015-2020) (K Doses)
    Table 29. Asia Pacific Porcine Vaccine Sales Market Share by Region (2015-2020)
    Table 30. Asia Pacific Porcine Vaccine Revenue by Region (2015-2020) (US$ Million)
    Table 31. Asia Pacific Porcine Vaccine Revenue Market Share by Region (2015-2020)
    Table 32. Latin America Porcine Vaccine Sales by Country (2015-2020) (K Doses)
    Table 33. Latin America Porcine Vaccine Sales Market Share by Country (2015-2020)
    Table 34. Latin America Porcine Vaccine Revenue by Country (2015-2020) (US$ Million)
    Table 35. Latin America Porcine Vaccine Revenue Market Share by Country (2015-2020)
    Table 36. Middle East and Africa Porcine Vaccine Sales by Country (2015-2020) (K Doses)
    Table 37. Middle East and Africa Porcine Vaccine Sales Market Share by Country (2015-2020)
    Table 38. Middle East and Africa Porcine Vaccine Revenue by Country (2015-2020) (US$ Million)
    Table 39. Middle East and Africa Porcine Vaccine Revenue Market Share by Country (2015-2020)
    Table 40. Global Porcine Vaccine Sales (K Doses) by Type (2015-2020)
    Table 41. Global Porcine Vaccine Sales Share by Type (2015-2020)
    Table 42. Global Porcine Vaccine Revenue (Million US$) by Type (2015-2020)
    Table 43. Global Porcine Vaccine Revenue Share by Type (2015-2020)
    Table 44. Global Porcine Vaccine Price (USD/Dose) by Type (2015-2020)
    Table 45. Global Porcine Vaccine Sales (K Doses) by Application (2015-2020)
    Table 46. Global Porcine Vaccine Sales Market Share by Application (2015-2020)
    Table 47. Global Porcine Vaccine Sales Growth Rate by Application (2015-2020)
    Table 48. Bayer AG. Corporation Information
    Table 49. Bayer AG. Description and Business Overview
    Table 50. Bayer AG. Porcine Vaccine Sales (K Doses), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2015-2020)
    Table 51. Bayer AG. Main Product
    Table 52. Bayer AG. Recent Development
    Table 53. Bimeda Animal Health Corporation Information
    Table 54. Bimeda Animal Health Description and Business Overview
    Table 55. Bimeda Animal Health Porcine Vaccine Sales (K Doses), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2015-2020)
    Table 56. Bimeda Animal Health Main Product
    Table 57. Bimeda Animal Health Recent Development
    Table 58. Boehringer Ingelheim GmbH Corporation Information
    Table 59. Boehringer Ingelheim GmbH Description and Business Overview
    Table 60. Boehringer Ingelheim GmbH Porcine Vaccine Sales (K Doses), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2015-2020)
    Table 61. Boehringer Ingelheim GmbH Main Product
    Table 62. Boehringer Ingelheim GmbH Recent Development
    Table 63. Ceva Sante Animale Corporation Information
    Table 64. Ceva Sante Animale Description and Business Overview
    Table 65. Ceva Sante Animale Porcine Vaccine Sales (K Doses), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2015-2020)
    Table 66. Ceva Sante Animale Main Product
    Table 67. Ceva Sante Animale Recent Development
    Table 68. Eli Lilly Corporation Information
    Table 69. Eli Lilly Description and Business Overview
    Table 70. Eli Lilly Porcine Vaccine Sales (K Doses), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2015-2020)
    Table 71. Eli Lilly Main Product
    Table 72. Eli Lilly Recent Development
    Table 73. Merck & Co., Inc. Corporation Information
    Table 74. Merck & Co., Inc. Description and Business Overview
    Table 75. Merck & Co., Inc. Porcine Vaccine Sales (K Doses), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2015-2020)
    Table 76. Merck & Co., Inc. Main Product
    Table 77. Merck & Co., Inc. Recent Development
    Table 78. Merial (Sanofi) Corporation Information
    Table 79. Merial (Sanofi) Description and Business Overview
    Table 80. Merial (Sanofi) Porcine Vaccine Sales (K Doses), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2015-2020)
    Table 81. Merial (Sanofi) Main Product
    Table 82. Merial (Sanofi) Recent Development
    Table 83. Vetoquinol Corporation Information
    Table 84. Vetoquinol Description and Business Overview
    Table 85. Vetoquinol Porcine Vaccine Sales (K Doses), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2015-2020)
    Table 86. Vetoquinol Main Product
    Table 87. Vetoquinol Recent Development
    Table 88. Zoetis, Inc. Corporation Information
    Table 89. Zoetis, Inc. Description and Business Overview
    Table 90. Zoetis, Inc. Porcine Vaccine Sales (K Doses), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2015-2020)
    Table 91. Zoetis, Inc. Main Product
    Table 92. Zoetis, Inc. Recent Development
    Table 93. Production Base and Market Concentration Rate of Raw Material
    Table 94. Key Suppliers of Raw Materials
    Table 95. Porcine Vaccine Distributors List
    Table 96. Porcine Vaccine Customers List
    Table 97. Porcine Vaccine Market Trends
    Table 98. Porcine Vaccine Opportunities and Drivers
    Table 99. Porcine Vaccine Market Challenges
    Table 100. Global Porcine Vaccine Sales (K Doses) Forecast by Type (2021-2026)
    Table 101. Global Porcine Vaccine Sales Market Share Forecast by Type (2021-2026)
    Table 102. Global Porcine Vaccine Revenue (Million US$) Forecast by Type (2021-2026)
    Table 103. Global Porcine Vaccine Revenue (Million US$) Market Share Forecast by Type (2021-2026)
    Table 104. Global Porcine Vaccine Sales (K Doses) Forecast by Application (2021-2026)
    Table 105. Global Porcine Vaccine Revenue (Million US$) Forecast by Application (2021-2026)
    Table 106. Global Porcine Vaccine Sales (K Doses) Forecast by Region (2021-2026)
    Table 107. Global Porcine Vaccine Sales Market Share Forecast by Region (2021-2026)
    Table 108. Global Porcine Vaccine Revenue Forecast by Region (2021-2026) (US$ Million)
    Table 109. Global Porcine Vaccine Revenue Market Share Forecast by Region (2021-2026)
    Table 110. Research Programs/Design for This Report
    Table 111. Key Data Information from Secondary Sources
    Table 112. Key Data Information from Primary Sources
List of Figures
    Figure 1. Picture of Porcine Vaccine
    Figure 2. Global Porcine Vaccine Sales Market Share by Type: 2020 VS 2026
    Figure 3. Inactivated Vaccines Product Picture
    Figure 4. Live Attenuated Vaccines Product Picture
    Figure 5. Toxoid Vaccines Product Picture
    Figure 6. Recombinant Vaccines Product Picture
    Figure 7. Conjugate Vaccines Product Picture
    Figure 8. DNA Vaccines Product Picture
    Figure 9. Global Porcine Vaccine Consumption Market Share by Application: 2020 VS 2026
    Figure 10. Veterinary Hospitals
    Figure 11. Hog/Pig Production Farm
    Figure 12. Global Porcine Vaccine Market Size 2015-2026 (US$ Million)
    Figure 13. Global Porcine Vaccine Sales Capacity (K Doses) (2015-2026)
    Figure 14. Global Porcine Vaccine Market Size Market Share by Region: 2020 Versus 2026
    Figure 15. Porcine Vaccine Sales Share by Manufacturers in 2020
    Figure 16. Global Porcine Vaccine Revenue Share by Manufacturers in 2019
    Figure 17. The Global 5 and 10 Largest Players: Market Share by Porcine Vaccine Revenue in 2019
    Figure 18. Porcine Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
    Figure 19. Global Porcine Vaccine Sales Market Share by Region (2015-2020)
    Figure 20. Global Porcine Vaccine Sales Market Share by Region in 2019
    Figure 21. Global Porcine Vaccine Revenue Market Share by Region (2015-2020)
    Figure 22. Global Porcine Vaccine Revenue Market Share by Region in 2019
    Figure 23. North America Porcine Vaccine Sales Market Share by Country in 2019
    Figure 24. North America Porcine Vaccine Revenue Market Share by Country in 2019
    Figure 25. U.S. Porcine Vaccine Sales Growth Rate (2015-2020) (K Doses)
    Figure 26. U.S. Porcine Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
    Figure 27. Canada Porcine Vaccine Sales Growth Rate (2015-2020) (K Doses)
    Figure 28. Canada Porcine Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
    Figure 29. Europe Porcine Vaccine Sales Market Share by Country in 2019
    Figure 30. Europe Porcine Vaccine Revenue Market Share by Country in 2019
    Figure 31. Germany Porcine Vaccine Sales Growth Rate (2015-2020) (K Doses)
    Figure 32. Germany Porcine Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
    Figure 33. France Porcine Vaccine Sales Growth Rate (2015-2020) (K Doses)
    Figure 34. France Porcine Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
    Figure 35. U.K. Porcine Vaccine Sales Growth Rate (2015-2020) (K Doses)
    Figure 36. U.K. Porcine Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
    Figure 37. Italy Porcine Vaccine Sales Growth Rate (2015-2020) (K Doses)
    Figure 38. Italy Porcine Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
    Figure 39. Russia Porcine Vaccine Sales Growth Rate (2015-2020) (K Doses)
    Figure 40. Russia Porcine Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
    Figure 41. Asia Pacific Porcine Vaccine Sales Market Share by Region in 2019
    Figure 42. Asia Pacific Porcine Vaccine Revenue Market Share by Region in 2019
    Figure 43. China Porcine Vaccine Sales Growth Rate (2015-2020) (K Doses)
    Figure 44. China Porcine Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
    Figure 45. Japan Porcine Vaccine Sales Growth Rate (2015-2020) (K Doses)
    Figure 46. Japan Porcine Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
    Figure 47. South Korea Porcine Vaccine Sales Growth Rate (2015-2020) (K Doses)
    Figure 48. South Korea Porcine Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
    Figure 49. India Porcine Vaccine Sales Growth Rate (2015-2020) (K Doses)
    Figure 50. India Porcine Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
    Figure 51. Australia Porcine Vaccine Sales Growth Rate (2015-2020) (K Doses)
    Figure 52. Australia Porcine Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
    Figure 53. Taiwan Porcine Vaccine Sales Growth Rate (2015-2020) (K Doses)
    Figure 54. Taiwan Porcine Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
    Figure 55. Indonesia Porcine Vaccine Sales Growth Rate (2015-2020) (K Doses)
    Figure 56. Indonesia Porcine Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
    Figure 57. Thailand Porcine Vaccine Sales Growth Rate (2015-2020) (K Doses)
    Figure 58. Thailand Porcine Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
    Figure 59. Malaysia Porcine Vaccine Sales Growth Rate (2015-2020) (K Doses)
    Figure 60. Malaysia Porcine Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
    Figure 61. Philippines Porcine Vaccine Sales Growth Rate (2015-2020) (K Doses)
    Figure 62. Philippines Porcine Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
    Figure 63. Vietnam Porcine Vaccine Sales Growth Rate (2015-2020) (K Doses)
    Figure 64. Vietnam Porcine Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
    Figure 65. Latin America Porcine Vaccine Sales Market Share by Country in 2019
    Figure 66. Latin America Porcine Vaccine Revenue Market Share by Country in 2019
    Figure 67. Mexico Porcine Vaccine Sales Growth Rate (2015-2020) (K Doses)
    Figure 68. Mexico Porcine Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
    Figure 69. Brazil Porcine Vaccine Sales Growth Rate (2015-2020) (K Doses)
    Figure 70. Brazil Porcine Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
    Figure 71. Argentina Porcine Vaccine Sales Growth Rate (2015-2020) (K Doses)
    Figure 72. Argentina Porcine Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
    Figure 73. Middle East and Africa Porcine Vaccine Sales Market Share by Country in 2019
    Figure 74. Middle East and Africa Porcine Vaccine Revenue Market Share by Country in 2019
    Figure 75. Turkey Porcine Vaccine Sales Growth Rate (2015-2020) (K Doses)
    Figure 76. Turkey Porcine Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
    Figure 77. Saudi Arabia Porcine Vaccine Sales Growth Rate (2015-2020) (K Doses)
    Figure 78. Saudi Arabia Porcine Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
    Figure 79. U.A.E Porcine Vaccine Sales Growth Rate (2015-2020) (K Doses)
    Figure 80. U.A.E Porcine Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
    Figure 81. Sales Market Share of Porcine Vaccine by Type (2015-2020)
    Figure 82. Sales Market Share of Porcine Vaccine by Type in 2020
    Figure 83. Global Porcine Vaccine Market Share by Price Range (2015-2020)
    Figure 84. Revenue Market Share of Porcine Vaccine by Type in 2019
    Figure 85. Global Porcine Vaccine Sales Growth by Type (2015-2020) (K Doses)
    Figure 86. Sales Market Share of Porcine Vaccine by Application (2015-2020)
    Figure 87. Sales Market Share of Porcine Vaccine by Application in 2020
    Figure 88. Revenue Share of Porcine Vaccine by Application (2015-2020)
    Figure 89. Revenue Share of Porcine Vaccine by Application in 2020
    Figure 90. Key Raw Materials Price Trend
    Figure 91. Manufacturing Cost Structure of Porcine Vaccine
    Figure 92. Manufacturing Process Analysis of Porcine Vaccine
    Figure 93. Porcine Vaccine Industrial Chain Analysis
    Figure 94. Channels of Distribution
    Figure 95. Distributors Profiles
    Figure 96. Porter's Five Forces Analysis
    Figure 97. Bottom-up and Top-down Approaches for This Report
    Figure 98. Data Triangulation
    Figure 99. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user(purchaser of the report) to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (10% Discount)
OUR CUSTOMER
Lukasiewicz Research Network
SIMILAR REPORTS
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

RELATED REPORTS

Global Dengue Testing Market Research Report 2024

120 Pages
Type: Report
Code: QYRE-Auto-26K6048
Mon Apr 15 00:00:00 UTC 2024

Add to Cart

Global Ebola Treatment Market Research Report 2024

120 Pages
Type: Report
Code: QYRE-Auto-20L6129
Mon Apr 15 00:00:00 UTC 2024

Add to Cart

Global Cytomegalovirus Infection Market Research Report 2024

120 Pages
Type: Report
Code: QYRE-Auto-4F6384
Mon Apr 15 00:00:00 UTC 2024

Add to Cart

Global IVD Infectious Diseases Market Research Report 2024

120 Pages
Type: Report
Code: QYRE-Auto-16N6009
Mon Apr 15 00:00:00 UTC 2024

Add to Cart